LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 38

Search options

  1. Article ; Online: A retrospective cohort study: is COVID-19 BNT162b2 mRNA vaccination a trigger factor for cluster headache?

    Aşkın Turan, Suna / Aydın, Şenay

    Acta neurologica Belgica

    2024  

    Abstract: OBJECTıVE: Cluster headache (CH) is a coronavirus 2019 (COVID-19) vaccination-related adverse event. There are a few case reports of relapses or de novo cluster episodes following the vaccine. The disease's pathophysiology is still not clear. The most ... ...

    Abstract OBJECTıVE: Cluster headache (CH) is a coronavirus 2019 (COVID-19) vaccination-related adverse event. There are a few case reports of relapses or de novo cluster episodes following the vaccine. The disease's pathophysiology is still not clear. The most widely accepted mechanism is activation of the trigeminocervical complex (TCC). However, the correlation between vaccination and CH is unexplainable. Its goal is to compare the CH bouts of patients before and after the vaccine.
    Methods: Patients with a history of CH and who had never experienced COVID-19 illness during the pandemic were included in this retrospective cohort analysis. The semi-structured survey was administered face to face to 24 CH patients (16 male). The headache features before and after vaccination were detailed in this survey.
    Results: 18 patients got vaccinated twice, and 6 of them had no vaccination. After the first vaccination, 83.3% of them had CH bout; after the second vaccination, 72.2% of them had CH bout. We divided headache episodes into three groups: (1) before vaccination, (2) after the first vaccination, and (3) after the second vaccination. The third group had a higher pain intensity (9.30 ± 0.630, p = 0.047) and remitting longer (20.00 ± 5.40 days, p = 0.019) than the other groups. The management of the 53.3% bouts after vaccinations was less effective than the usual episodes.
    Conclusion: Most ECH patients experienced new bouts more intense and longer duration after vaccinations than their previous bouts, the mechanism, and pathogenesis of the bouts are the subject of future research. The new studies can be a light for understanding the CH pathophysiology more deeply.
    Language English
    Publishing date 2024-04-15
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 127315-2
    ISSN 2240-2993 ; 0300-9009
    ISSN (online) 2240-2993
    ISSN 0300-9009
    DOI 10.1007/s13760-024-02536-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Karpal tünel sendromu tedavisinde steroid enjeksiyonun uyku hijyeni üzerindeki etkisi.

    Aşkın Turan, Suna / Aydın, Şenay

    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology

    2021  Volume 33, Issue 2, Page(s) 96–102

    Abstract: Objectives: Carpal tunnel syndrome (CTS) is the most seen entrapment neuropathy. CTS is a complex syndrome arisen with entrapment of median nerve at wrist. Pain worst at night, paresthesia, hypoesthesia, paralysis, and muscle atrophy can be seen through ...

    Title translation The effect of steroid injection treatment with carpal tunnel syndrome on sleep hygiene.
    Abstract Objectives: Carpal tunnel syndrome (CTS) is the most seen entrapment neuropathy. CTS is a complex syndrome arisen with entrapment of median nerve at wrist. Pain worst at night, paresthesia, hypoesthesia, paralysis, and muscle atrophy can be seen through nerve entrapment level. Besides, we see negative symptoms for sleep in our practice. It is known the effect of invasive and non-invasive treatments on the sleep. We aimed to search the effect of treatment of CTS on the sleep modalities.
    Methods: In our study, the effect of injection treatment of CTS patients diagnosed clinically with electrophysiological methods in neurology clinic, on sleep modalities. After excluding the secondary reasons of CTS; patients responded to visual analog scale (VAS), symptom, and functional scales of Boston questionnaire (BQ-FS), Leeds Assessment of Neuropathic Symptoms and Signs, Pittsburg sleep quality index (PSQI), insomnia severity index (ISI), sleep hygiene index (SHI), Epworth sleepiness scale, Beck depression scale, and Beck anxiety scale.
    Results: Twenty-nine patients (2 males and 27 females) were enrolled. After treatment, VAS, BQ-FS, LANNS, PSQI, ISI, and SHI both resulted in a significant reduction.
    Conclusion: Sleep hygiene is affected negatively in CTS patients. A healing effect is observed on the quality of sleep impaired by the injection treatment of CTS.
    MeSH term(s) Carpal Tunnel Syndrome/drug therapy ; Female ; Humans ; Male ; Pain Measurement ; Sleep Hygiene ; Steroids ; Visual Analog Scale
    Chemical Substances Steroids
    Language Turkish
    Publishing date 2021-04-12
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 1283669-2
    ISSN 1300-0012
    ISSN 1300-0012
    DOI 10.14744/agri.2020.09735
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Ultrasound-Guided Combined Greater Occipital Nerve Block at the C2 Level with Trapezius Trigger Point Injection and Supraorbital-Supratrochlear Nerve Block: More Effective on Allodynia and Disability in Chronic Migraine.

    Turan, Suna Aşkın / Aydın, Şenay / Gözükara, Melih G / Çabalar, Murat

    Annals of Indian Academy of Neurology

    2023  Volume 26, Issue 6, Page(s) 943–951

    Abstract: Background: Chronic migraine (CM) patients with cutaneous allodynia (CA) show a poor response to treatment. Long-term studies have yet to be conducted to demonstrate the efficacy of blocks on CA. This study evaluated the improvement in allodynia and ... ...

    Abstract Background: Chronic migraine (CM) patients with cutaneous allodynia (CA) show a poor response to treatment. Long-term studies have yet to be conducted to demonstrate the efficacy of blocks on CA. This study evaluated the improvement in allodynia and disability in CM treated with ultrasound (US)-guided blocks.
    Methods: In this prospective, non-randomized comparative study, 60 CM patients with CA were evaluated for the clinical effectiveness of the therapy using the numeric rating scale (NRS), headache impact test-6 (HIT-6), brush allodynia test, and allodynia symptom checklist (ASC-12). At the first visit, tenderness in the nerve or trapezius muscle was confirmed in the intervention group. US-guided greater occipital nerve block (GONB), GONB, and trapezius muscle injection (TPI), or GONB, TPI, and peripheral trigeminal nerve block (PTNB), respectively, were performed four times once a week for a month. Initial and third-month assessments were performed.
    Results: The ASC-12 scores decreased in the GONB+TPI+PTNB and GONB groups more than the GONB+TPI group (mean rank, respectively, 26.86, 27.40, 38.39;
    Conclusions: GONB+TPI+PTNB was more successful in alleviating allodynia and disability.
    Language English
    Publishing date 2023-12-15
    Publishing country India
    Document type Journal Article
    ZDB-ID 2240174-X
    ISSN 1998-3549 ; 0972-2327
    ISSN (online) 1998-3549
    ISSN 0972-2327
    DOI 10.4103/aian.aian_677_23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Correlation between Pulmonary Embolism and Sleep Apnea.

    Kahya, Özlem / Sökücü, Sinem Nedime / Özdemir, Cengiz / Onur, Seda Tural / Sarı, Merve / Aydın, Şenay

    Noro psikiyatri arsivi

    2023  Volume 60, Issue 2, Page(s) 143–150

    Abstract: Introduction: It has been shown that there is a correlation between Obstructive Sleep Apnea Syndrome (OSAS) and pulmonary thromboembolism (PTE); OSAS is a risk factor for PTE. We aimed to evaluate the frequency of OSAS in PTE patients, the correlation ... ...

    Abstract Introduction: It has been shown that there is a correlation between Obstructive Sleep Apnea Syndrome (OSAS) and pulmonary thromboembolism (PTE); OSAS is a risk factor for PTE. We aimed to evaluate the frequency of OSAS in PTE patients, the correlation of OSAS with the severity of PTE, and its effect on 1-month mortality in PTE patients.
    Methods: This single-center, prospective, comparative case control study contains 198 patients diagnosed with non-massive PTE in our hospital between the dates of 01/07/2018-04/01/2020 who were confirmed by imaging methods. Daytime sleepiness was assessed with Epworth questionnaires, and OSAS risk was assessed with Berlin, STOP, STOP-BANG sleep questionnaires. Alongside demographic and clinical data, comorbidities, Pulmonary Embolism Severity Index (PESI), simplified PESI (sPESI), WELLS scores, troponin, D-dimer values, echocardiyography (ECHO) findings were also examined. Epworth, Berlin, STOP, STOP-BANG sleep groups were compared in terms of PTE parameters.
    Results: A hundred and thirty-eight patients (69.6%) was assesed as high risk group according to Berlin, meanwhile STOP-BANG defined 174 patients (87.8%), furthermore STOP has considered 152 patients in the high risk group (76.7%) and Epworth questionnaire determined this number as 127 (64.1%). As a result of the logistic regression analysis, statistically significant correlation was found between Berlin score and heart failure, PESI, sPESI and troponin values; between Epworth score and WELLS score; between STOP-BANG score and PESI score (p<0.05). During the 1-month follow-up period, 9 of the patients were exitus and mortality was 4.5%.
    Conclusion: OSAS risk is more common in patients with PTE and it may be a risk factor for PTE. It has been shown that the risk of OSAS may aggravate PTE severity and prognosis.
    Language English
    Publishing date 2023-05-18
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 2565770-7
    ISSN 1300-0667
    ISSN 1300-0667
    DOI 10.29399/npa.28210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Triglyceride-glucose index as a predictor of obstructive sleep apnoea severity in the absence of traditional risk factors.

    Sökücü, Sinem Nedime / Aydın, Şenay / Satıcı, Celal / Tural Önür, Seda / Özdemir, Cengiz

    Arquivos de neuro-psiquiatria

    2023  Volume 81, Issue 10, Page(s) 891–897

    Abstract: Objective: We evaluated the association between the triglyceride-glucose (TG) index, a marker of insulin resistance, and obstructive sleep apnoea (OSA) severity in patients without diabetes mellitus, obesity, and metabolic syndrome.: Methods: This ... ...

    Title translation Índice de triglicerídeos-glicose como preditor de gravidade da apneia obstrutiva do sono na ausência de fatores de risco tradicionais.
    Abstract Objective: We evaluated the association between the triglyceride-glucose (TG) index, a marker of insulin resistance, and obstructive sleep apnoea (OSA) severity in patients without diabetes mellitus, obesity, and metabolic syndrome.
    Methods: This retrospective cohort study included 1,527 patients. We used univariate and multivariate analyses to identify the independent predictors associated with OSA.
    Results: Most patients were males (81.5%) with a mean age of 43.9 ± 11.1 (15-90) years. Based on the apnoea-hypopnea index (AHI), 353 (23.1%) patients were included in the control group, whereas 32.4%, 23.5%, and 21% had mild, moderate, and severe OSA, respectively. The TG index values demonstrated significant associations with OSA patients compared with the control group (
    Conclusion: The TG index is independently associated with increased risk for OSA. This indicates that this index, a marker for disease severity, can be used to identify severe OSA patients on waiting lists for PSG.
    MeSH term(s) Male ; Humans ; Adult ; Middle Aged ; Female ; Triglycerides ; Glucose ; Retrospective Studies ; Risk Factors ; Sleep Apnea, Obstructive/diagnosis ; Sleep Apnea, Obstructive/complications
    Chemical Substances Triglycerides ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2023-11-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 418916-4
    ISSN 1678-4227 ; 0004-282X
    ISSN (online) 1678-4227
    ISSN 0004-282X
    DOI 10.1055/s-0043-1776411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Does smoking impair sleep hygiene?

    Hattatoğlu, Didem Görgün / Aydin, Şenay / Yildiz, Birsen Pınar

    Arquivos de neuro-psiquiatria

    2021  Volume 79, Issue 12, Page(s) 1123–1128

    Abstract: Background: Sleep architecture and sleep hygiene might be disrupted by several pathogenetic mechanisms, and the effect of smoking has not been evaluated.: Objective: To investigate the effect of smoking on sleep hygiene behaviors that might be ... ...

    Abstract Background: Sleep architecture and sleep hygiene might be disrupted by several pathogenetic mechanisms, and the effect of smoking has not been evaluated.
    Objective: To investigate the effect of smoking on sleep hygiene behaviors that might be associated with the deterioration of quality-of-life (QoL) parameters.
    Methods: In a prospective cross-sectional study, smokers (n=114) and nonsmokers (n=119) were included. The Pittsburgh Sleep Quality İndex (PSQI), the Epworth Daytime Sleepiness Scale (ESS), the Sleep Hygiene Index (SHI), and the Short Form-36 quality of life scale (SF-36) were applied.
    Results: We found that none of the components, as well as the PSQI total score were affected in smokers compared with the nonsmoker controls (65.5% of smokers had poor sleep compared to 62.5% of nonsmokers). Although smokers tend to get out of bed at different times from day to day and do important work before bedtime (components of the SHI) more often than non-smokers, no significant differences were detected between groups in any component and SHI total score (27.91±6.72 for smokers and 29.23±8.0 for non-smokers). ESS, depression and anxiety symptoms, and SHI scores in smokers with poor sleep quality were significantly different compared with smokers that had normal sleep quality. Both PSQI and SHI scores were inversely associated with QoL parameters.
    Conclusions: Our results suggest that smoking by itself is not associated with poor sleep hygiene or sleep quality. It can be concluded that worse SHI and quality of sleep negatively affect QoL, depression, and anxiety in smokers.
    MeSH term(s) Cross-Sectional Studies ; Humans ; Prospective Studies ; Quality of Life ; Sleep ; Sleep Hygiene ; Sleep Quality ; Sleep Wake Disorders/epidemiology ; Sleep Wake Disorders/etiology ; Smoking/adverse effects
    Language English
    Publishing date 2021-12-01
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 418916-4
    ISSN 1678-4227 ; 0004-282X
    ISSN (online) 1678-4227
    ISSN 0004-282X
    DOI 10.1590/0004-282X-ANP-2020-0578
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Electromyographic and sonographic assessment of diaphragm dysfunction in patients who recovered from the COVID-19 pneumonia.

    Satıcı, Celal / Aydın, Şenay / Tuna, Lale / Köybaşı, Gizem / Koşar, Filiz

    Tuberkuloz ve toraks

    2021  Volume 69, Issue 3, Page(s) 425–428

    Title translation COVID-19 pnömonisini atlatan hastalarda diyafram disfonksiyonunun elektromiyografik ve sonografik değerlendirmesi.
    MeSH term(s) COVID-19 ; Diaphragm/diagnostic imaging ; Humans ; SARS-CoV-2 ; Ultrasonography
    Language English
    Publishing date 2021-09-27
    Publishing country Turkey
    Document type Letter
    ZDB-ID 2468802-2
    ISSN 0494-1373
    ISSN 0494-1373
    DOI 10.5578/tt.20219718
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Triglyceride-glucose index as a predictor of obstructive sleep apnoea severity in the absence of traditional risk factors

    Sökücü, Sinem Nedime / Aydın, Şenay / Satıcı, Celal / Tural Önür, Seda / Özdemir, Cengiz

    Arquivos de Neuro-Psiquiatria

    2023  Volume 81, Issue 10, Page(s) 891–897

    Abstract: Objective: We evaluated the association between the triglyceride–glucose (TG) index, a marker of insulin resistance, and obstructive sleep apnoea (OSA) severity in patients without diabetes mellitus, obesity, and metabolic syndrome.: Methods: This ... ...

    Abstract Objective: We evaluated the association between the triglyceride–glucose (TG) index, a marker of insulin resistance, and obstructive sleep apnoea (OSA) severity in patients without diabetes mellitus, obesity, and metabolic syndrome.
    Methods: This retrospective cohort study included 1,527 patients. We used univariate and multivariate analyses to identify the independent predictors associated with OSA.
    Results: Most patients were males (81.5%) with a mean age of 43.9 ± 11.1 (15–90) years. Based on the apnoea–hypopnea index (AHI), 353 (23.1%) patients were included in the control group, whereas 32.4%, 23.5%, and 21% had mild, moderate, and severe OSA, respectively. The TG index values demonstrated significant associations with OSA patients compared with the control group ( p  = 0.001). In addition, the mean values of the oxygen desaturation index (ODI), AHI, minimum oxygen saturation, and total sleep time percentage with saturation below 90% demonstrated statistically significant differences among the TG index groups (p: 0.001; p:0.001; p:0.001; p:0.003). The optimal TG index cutoff value to predict OSA was 8.615 (AUC = 0.638, 95% CI = 0.606–0.671, p  = 0.001). In multivariate logistic regression analysis, after adjusting for age, sex, and body mass index, the TG index was independently associated with OSA patients.
    Conclusion: The TG index is independently associated with increased risk for OSA. This indicates that this index, a marker for disease severity, can be used to identify severe OSA patients on waiting lists for PSG.
    Keywords Sleep Apnea, Obstructive ; Prognosis ; Triglyceride Glucose Index ; Apneia Obstrutiva do Sono ; Prognóstico ; Índice Triglicerídeos e Glicose
    Language English
    Publishing date 2023-10-01
    Publisher Thieme Revinter Publicações Ltda.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 418916-4
    ISSN 1678-4227 ; 0004-282X
    ISSN (online) 1678-4227
    ISSN 0004-282X
    DOI 10.1055/s-0043-1776411
    Database Thieme publisher's database

    More links

    Kategorien

  9. Article: Does smoking impair sleep hygiene?

    HATTATOĞLU, Didem Görgün / AYDIN, Şenay / YILDIZ, Birsen Pınar

    Arquivos de Neuro-Psiquiatria

    2021  Volume 79, Issue 12, Page(s) 1–8

    Abstract: Background: Sleep architecture and sleep hygiene might be disrupted by several pathogenetic mechanisms, and the effect of smoking has not been evaluated. Objective: To investigate the effect of smoking on sleep hygiene behaviors that might be associated ... ...

    Abstract Background: Sleep architecture and sleep hygiene might be disrupted by several pathogenetic mechanisms, and the effect of smoking has not been evaluated. Objective: To investigate the effect of smoking on sleep hygiene behaviors that might be associated with the deterioration of quality-of-life (QoL) parameters. Methods: In a prospective cross-sectional study, smokers (n=114) and nonsmokers (n=119) were included. The Pittsburgh Sleep Quality İndex (PSQI), the Epworth Daytime Sleepiness Scale (ESS), the Sleep Hygiene Index (SHI), and the Short Form-36 quality of life scale (SF-36) were applied. Results: We found that none of the components, as well as the PSQI total score were affected in smokers compared with the nonsmoker controls (65.5% of smokers had poor sleep compared to 62.5% of nonsmokers). Although smokers tend to get out of bed at different times from day to day and do important work before bedtime (components of the SHI) more often than non-smokers, no significant differences were detected between groups in any component and SHI total score (27.91±6.72 for smokers and 29.23±8.0 for non-smokers). ESS, depression and anxiety symptoms, and SHI scores in smokers with poor sleep quality were significantly different compared with smokers that had normal sleep quality. Both PSQI and SHI scores were inversely associated with QoL parameters. Conclusions: Our results suggest that smoking by itself is not associated with poor sleep hygiene or sleep quality. It can be concluded that worse SHI and quality of sleep negatively affect QoL, depression, and anxiety in smokers.
    Keywords Sleep Hygiene ; Smoking ; Sleep Wake Disorders ; Higiene do Sono ; Fumar ; Transtornos do Sono-Vigília
    Language English
    Publishing date 2021-12-01
    Publisher Thieme Revinter Publicações Ltda.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 418916-4
    ISSN 1678-4227 ; 0004-282X
    ISSN (online) 1678-4227
    ISSN 0004-282X
    DOI 10.1590/0004-282X-ANP-2020-0578
    Database Thieme publisher's database

    More links

    Kategorien

  10. Article ; Online: Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.

    Gürer, Reyhan / Aydın, Şenay / Özkara, Çiğdem

    Seizure

    2019  Volume 70, Page(s) 43–48

    Abstract: Purpose: There are conflicting data regarding the drug dose that is sufficient to achieve seizure control as well as the parameters of seizure remission in juvenile myoclonic epilepsy (JME). The present study aimed to identify factors that contribute to ...

    Abstract Purpose: There are conflicting data regarding the drug dose that is sufficient to achieve seizure control as well as the parameters of seizure remission in juvenile myoclonic epilepsy (JME). The present study aimed to identify factors that contribute to seizure control in JME and to evaluate factors associated with JME remission and the efficacy of low-dose valproic acid (VPA) therapy.
    Methods: This retrospective, cross-sectional study included a total of 215 patients (121 female and 94 male; mean age: 28.03 ± 8.43 [14-59] years) diagnosed with JME. The patients were divided into remission and refractory groups. Remission was defined as a seizure-free (myoclonic, absence, and/or generalized tonic-clonic) period of at least 2 years. Patients in whom remission was achieved with VPA monotherapy were further divided into two groups according to the use of low-dose VPA therapy (VPA ≤ 750 mg/day and >750 mg/day). Potential contributing factors were evaluated in terms of the relationship between the dose and the remission parameters.
    Results: Remission was achieved with VPA monotherapy in 116 patients (87.9%) in the remission group; the VPA dose was ≤750 mg in 77.6% of the patients. The dose of VPA was higher in patients with absence seizure who achieved remission (p = 0.026). Remission was achieved with a lower dose of VPA in females than in males (p = 0.004).
    Conclusions: Low-dose VPA can be used to achieve remission in JME. However, identification at follow-up visits of the factors that may affect remission may change the planned effective dose of VPA.
    MeSH term(s) Adolescent ; Adult ; Anticonvulsants/therapeutic use ; Cross-Sectional Studies ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myoclonic Epilepsy, Juvenile/drug therapy ; Pregnancy ; Pregnancy Complications/drug therapy ; Retrospective Studies ; Sex Factors ; Treatment Outcome ; Valproic Acid/therapeutic use ; Young Adult
    Chemical Substances Anticonvulsants ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2019-06-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1137610-7
    ISSN 1532-2688 ; 1059-1311
    ISSN (online) 1532-2688
    ISSN 1059-1311
    DOI 10.1016/j.seizure.2019.06.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top